1. Home
  2. ADIL vs POLA Comparison

ADIL vs POLA Comparison

Compare ADIL & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • POLA
  • Stock Information
  • Founded
  • ADIL 2010
  • POLA 1979
  • Country
  • ADIL United States
  • POLA United States
  • Employees
  • ADIL N/A
  • POLA N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • ADIL Health Care
  • POLA Miscellaneous
  • Exchange
  • ADIL Nasdaq
  • POLA Nasdaq
  • Market Cap
  • ADIL 7.7M
  • POLA 8.7M
  • IPO Year
  • ADIL 2018
  • POLA 2016
  • Fundamental
  • Price
  • ADIL $0.40
  • POLA $4.87
  • Analyst Decision
  • ADIL Strong Buy
  • POLA
  • Analyst Count
  • ADIL 2
  • POLA 0
  • Target Price
  • ADIL $4.75
  • POLA N/A
  • AVG Volume (30 Days)
  • ADIL 745.4K
  • POLA 55.5K
  • Earning Date
  • ADIL 11-12-2025
  • POLA 11-13-2025
  • Dividend Yield
  • ADIL N/A
  • POLA N/A
  • EPS Growth
  • ADIL N/A
  • POLA N/A
  • EPS
  • ADIL N/A
  • POLA N/A
  • Revenue
  • ADIL N/A
  • POLA $11,967,000.00
  • Revenue This Year
  • ADIL N/A
  • POLA N/A
  • Revenue Next Year
  • ADIL N/A
  • POLA N/A
  • P/E Ratio
  • ADIL N/A
  • POLA N/A
  • Revenue Growth
  • ADIL N/A
  • POLA 0.14
  • 52 Week Low
  • ADIL $0.22
  • POLA $1.53
  • 52 Week High
  • ADIL $1.30
  • POLA $5.59
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 58.88
  • POLA 70.96
  • Support Level
  • ADIL $0.37
  • POLA $3.20
  • Resistance Level
  • ADIL $0.41
  • POLA $5.59
  • Average True Range (ATR)
  • ADIL 0.02
  • POLA 0.46
  • MACD
  • ADIL 0.01
  • POLA 0.12
  • Stochastic Oscillator
  • ADIL 75.00
  • POLA 63.05

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: